Filing Details

Accession Number:
0001209191-19-011846
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-20 20:44:45
Reporting Period:
2019-02-15
Accepted Time:
2019-02-20 20:44:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1299130 Pacific Biosciences Of California Inc. PACB Laboratory Analytical Instruments (3826) 161590339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1317102 Michael Hunkapiller Pacific Biosciences Of California, Inc.
1305 O'Brien Drive
Menlo Park CA 94025
Chairman, Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-15 38,750 $0.00 2,388,750 No 4 A Direct
Common Stock Acquisiton 2019-02-15 22,800 $0.00 2,411,550 No 4 A Direct
Common Stock Disposition 2019-02-19 13,335 $7.19 2,398,215 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date.
  2. Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units.
  3. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards.
  4. This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.